Search research articles
Contact Us
Filters
Showing results (171-180 of 442) with videos related to
Page
of 45
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
April 22, 2021
Influence of habitual aerobic and resistance exercise on cerebrovascular reactivity in healthy young adults
Adam T Corkery, Anna J Howery, Kathleen B Miller, et al.
Psychology in the Schools
|
January 31, 2023
Unpacking the social-emotional health of education support professionals during the COVID-19 pandemic
Lauren H Naples, Christina Cipriano, Abigail Eveleigh, et al.
International Journal of STD & AIDS
|
November 1, 1994
Screening for tuberculosis in an east London HIV clinic
C M Theodore, G E Forster, B T Goh, et al.
Gene Therapy
|
December 25, 2009
Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
K Anwer, M N Barnes, J Fewell, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 22, 2019
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
Marie T Borin, Arthur Lo, Chris N Barnes, et al.
Journal of Emergencies, Trauma, and Shock
|
June 3, 2011
Adhesive bowel obstruction? Not always
D Mittapalli, B J Sebastian, E Leung, et al.
Frontiers in Neuroscience
|
May 24, 2024
Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism
Sarah H Shrader, Nicholas Mellen, Jun Cai, et al.
Respiratory Research
|
November 4, 2017
A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease
Krishna K Pudi, Chris N Barnes, Edmund J Moran, et al.
Experimental Physiology
|
May 28, 2026
Experimental Physiology Special Issue: Exercise as Medicine
Ronan M G Berg, Colleen S Deane, Jill N Barnes, et al.
Infection and Immunity
|
April 18, 2000
Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors
P Vukovic, P M Hogarth, N Barnes, et al.
Page
of 45
Search research articles
Search
Showing results (171-180 of 442) with videos related to
Sort By:
Page
of 45
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
April 22, 2021
Influence of habitual aerobic and resistance exercise on cerebrovascular reactivity in healthy young adults
Adam T Corkery, Anna J Howery, Kathleen B Miller, et al.
Psychology in the Schools
|
January 31, 2023
Unpacking the social-emotional health of education support professionals during the COVID-19 pandemic
Lauren H Naples, Christina Cipriano, Abigail Eveleigh, et al.
International Journal of STD & AIDS
|
November 1, 1994
Screening for tuberculosis in an east London HIV clinic
C M Theodore, G E Forster, B T Goh, et al.
Gene Therapy
|
December 25, 2009
Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer
K Anwer, M N Barnes, J Fewell, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 22, 2019
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
Marie T Borin, Arthur Lo, Chris N Barnes, et al.
Journal of Emergencies, Trauma, and Shock
|
June 3, 2011
Adhesive bowel obstruction? Not always
D Mittapalli, B J Sebastian, E Leung, et al.
Frontiers in Neuroscience
|
May 24, 2024
Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism
Sarah H Shrader, Nicholas Mellen, Jun Cai, et al.
Respiratory Research
|
November 4, 2017
A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease
Krishna K Pudi, Chris N Barnes, Edmund J Moran, et al.
Experimental Physiology
|
May 28, 2026
Experimental Physiology Special Issue: Exercise as Medicine
Ronan M G Berg, Colleen S Deane, Jill N Barnes, et al.
Infection and Immunity
|
April 18, 2000
Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors
P Vukovic, P M Hogarth, N Barnes, et al.
Page
of 45